Systematic Review: microRNAs as Potential Biomarkers in Mild Cognitive Impairment Diagnosis

The rate of progression from Mild Cognitive Impairment (MCI) to Alzheimer's disease (AD) is estimated at >10% per year, reaching up to 80–90% after 6 years. MCI is considered an indicator of early-stage AD. In this context, the diagnostic screening of MCI is crucial for detecting individuals...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogonowski, Natalia, Salcidua, Stefanny, Leon, Tomas, Chamorro-Veloso, Nayaret, Valls, Cristian, Avalos, Constanza, Bisquertt, Alejandro, Rentería, Miguel E., Orellana, Paulina, Duran-Aniotz, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790149/
https://www.ncbi.nlm.nih.gov/pubmed/35095478
http://dx.doi.org/10.3389/fnagi.2021.807764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8790149/
https://www.ncbi.nlm.nih.gov/pubmed/35095478
http://dx.doi.org/10.3389/fnagi.2021.807764

Ejemplares similares